Glioblastoma, previously known as glioblastoma multiforme, is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival. Initial signs and symptoms are nonspecific and may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.
Facts
Classification
Body SystemSourced to the subject's own account ICD-10 Chapter Communicable or Non-communicable Transmission RouteSourced to the subject's own account Causative Agent
Causative Agent (category)Sourced to the subject's own accountIdiopathic / Multifactorial 1 First Described Connections
Treated By
Source Alternating electric field therapy (Wikipedia)
Sources
1. Glioblastoma (Wikipedia)
Wikipediainfobox causes
causes: Usually unclear
Wikipedia infobox, field/specialty parameter
Neuro-oncology, neurosurgery
Lead section, transmission-route statement
Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain, and has a very poor prognosis for survival.
View the Source 2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter IIQuote, List of chapters, Chapter II
Neoplasms
3. World Health Organization: Noncommunicable diseases (fact sheet)
World Health OrganizationMain Types sectionQuote, Main Types section
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
4. Glioblastoma (Wikipedia)
Term glioblastoma multiforme introduced in 1926 by Bailey and Cushing, History sectionView the Source Alternating electric field therapy (Wikipedia)
Treated By: Alternating electric field therapy, Lead: treats GlioblastomaQuote, Treated By: Alternating electric field therapy, Lead: treats Glioblastoma
A TTField-treatment device manufactured by the Israeli company Novocure is approved in the United States and Europe for the treatment of newly diagnosed and recurrent glioblastoma, malignant pleural mesothelioma (MPM), and is undergoing clinical trials for several other tumor types.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.